WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 68.30
-1.10 (-1.59%)
At close: Mar 27, 2026
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.11 billion as of March 27, 2026. Its market cap has decreased by -3.23% in one year.
Market Cap
3.11B
Enterprise Value
3.62B
Revenue
1.11B
Ranking
n/a
PE Ratio
15.10
Stock Price
68.30
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.11B, a decrease of -9.45%. That is a compound annual growth rate of -4.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.11B | -6.95% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.80B |
| InnoCare Optoelectronics | 5.74B |
| Bonraybio | 4.12B |
| Medimaging Integrated Solution | 2.87B |
| A Plus Biotechnology | 2.74B |
| Dynamic Medical Technologies | 2.44B |
| Applied BioCode | 2.40B |
| Wellell | 2.25B |